Seer to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Seer, Inc. (Nasdaq: SEER), a life sciences company, will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 8:40 a.m. PT. The event will feature a presentation and Q&A session with company management. A live webcast will be accessible through the Investor section of Seer's website, with an archived replay available post-conference.

Seer focuses on delivering unbiased, rapid, and scalable proteomics information, primarily through its Proteograph™, enhancing scientific research efficiency.

REDWOOD CITY, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, today announced the company will be participating in the upcoming 39^th Annual J.P. Morgan Healthcare Conference.

Seer’s management is scheduled to present and participate in a Q&A session on Monday, January 11 at 8:40 a.m. Pacific Time / 11:40 a.m. Eastern Time. A live webcast of the virtual session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.

About Seer
Seer is a life sciences company focused on enabling exceptional scientific outcomes by commercializing transformative products that will drive breakthrough ideas by unlocking the deep, unbiased biological information that can make them a reality. Seer is developing its Proteograph™, which is an integrated solution consisting of consumables, automation instrumentation and proprietary software that performs deep, unbiased proteomics analysis at scale in a matter of hours. Seer designed the Proteograph to be efficient and easy-to-use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution broadly available to life sciences researchers.

Investor Contact
Carrie Mendivil
investor@seer.bio

FAQ

When is Seer participating in the J.P. Morgan Healthcare Conference?

Seer is scheduled to participate on January 11, 2021, at 8:40 a.m. PT.

How can I watch Seer's presentation at the J.P. Morgan Healthcare Conference?

You can watch the live webcast on the Investor section of Seer's website.

What is the Proteograph™ developed by Seer?

The Proteograph™ is an integrated solution for deep, unbiased proteomics analysis, designed to be efficient and easy to use.

What does Seer focus on in its operations?

Seer focuses on enabling exceptional scientific outcomes through scalable proteomics information.

Where can I find the archived replay of Seer's conference presentation?

The archived replay will be available on Seer's website following the conference.